Science Comes to a Halt in Ukraine, at Risk in Russia

The Russian invasion into Ukraine that began a week ago has forced Ukrainian scientists to abandon their labs and is putting research in Russia in peril.

Written byAnna Azvolinsky
| 6 min read
map of Ukraine
Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

On Monday (February 28), the fifth day of Russia’s military assault on Ukraine, Alla Mironenko—a physician-scientist and virologist and head of the Influenza Laboratory Ukrainian Center of Influenza and Acute Respiratory Infections Ministry of Health in Kyiv, Ukraine—drove the five kilometers to her laboratory with her husband. “I usually walk, but it is not possible now,” she told The Scientist by telephone later that day. A lone security guard let her in the laboratory building. The laboratories were empty, the heat turned off. Mironenko’s husband waited for her while she did a sweep of the lab. Although the lab does quite a bit of cell culture work, luckily, at the moment, they didn’t have any cells growing. Mironenko checked that the laboratory was in order, closed all of the windows, watered the plants in her office and those of her colleagues, and unplugged the centrifuges and other instruments.

New multiplex ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies